For subscribers
Singapore, US researchers studying drug to treat haemorrhagic stroke
Sign up now: Get ST's newsletters delivered to your inbox
Assistant Professor Nicolas Kon from the National Neuroscience Institute and Associate Professor Michael Lucas James from Duke University School of Medicine are the lead researchers in the trials.
PHOTO: NATIONAL NEUROSCIENCE INSTITUTE
Felicia Choo
Follow topic:
Non-surgical treatment for people who have suffered a more severe form of haemorrhagic stroke could be on the cards if trials here and in the United States prove successful.
Researchers are testing a protein-based compound that reduces inflammation in the brain after injury. It would complement existing treatment for the affliction, which makes up about one-fifth of all stroke cases here but caused 44 per cent of all stroke-related deaths in 2016.
